Search

everythinglearnresearchcommunity

for

Search:↓

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Mice with autoimmune hair loss showed signs of heart problems.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Erdr1 could be a new marker for diagnosing hair loss.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

The new skin model can predict how chemicals might cause skin allergies.